4.3 Article

Aberrant Peripheral Immune Function in a Good Syndrome Patient

Journal

JOURNAL OF IMMUNOLOGY RESEARCH
Volume 2018, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2018/6212410

Keywords

-

Categories

Funding

  1. National Natural Science Foundation of China [81772779]
  2. The Six Top Talent Project of Jiangsu Province [2015-WSN-034]
  3. Jiangsu Province's Key Provincial Talents Program [ZDRCA2016003]
  4. Natural Science Youth Foundation of Jiangsu Province [BK20151029]
  5. Natural Science Youth Foundation of China [81501817]
  6. Key Laboratory for Medicine of Jiangsu Province of China [ZDXKB2016005]
  7. Priority Academic Program Development of Jiangsu Higher Education Institutions

Ask authors/readers for more resources

Good's syndrome (GS) is often accompanied by recurrent respiratory infections and chronic diarrhea. The main purpose was to evaluate the peripheral immune status of a GS patient after thymoma resection. Twenty healthy volunteers were recruited as healthy controls (HCs). Flow cytometry was applied to determine the proportions of circuiting CD4(+) T cells, CD8(+) T cells, gamma delta T cells, and regulatory T (Treg) cells in our GS patient. We also examined the proliferation capability of ex vivo CD4(+) T cells and detected the levels of cytokines interferon- (IFN-) gamma and interleukin-17A secreted by ex vivo immune cells from this GS patient. Compared with healthy control subjects, this GS patient had fewer B cells, an inverted ratio of CD4(+)/CD8(+) cells, and more Treg cells in his peripheral blood. Additionally, the patient's V delta 2 T cell levels were significantly decreased despite having a normal percentage of gamma delta T cells. Ex vivo peripheral CD4(+) T cells from the patient showed insufficient proliferation and division potential as well as excessive expression of PD-1. Moreover, IFN-gamma was predominantly derived from CD8(+) T cells in this GS patient, rather than from CD4(+) T cells and gamma delta T cells. This GS patient had impaired T and B cell immunological alternations and cytokine disruptions after thymectomy. Detailed research should focus on therapies that can adjust the immune status in such patients for a better outcome.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available